Today: 30 June 2026
Shell share price today: What to watch before London opens as oil jumps and buybacks roll on
24 February 2026
1 min read

Shell share price today: What to watch before London opens as oil jumps and buybacks roll on

London, Feb 24, 2026, 07:44 GMT — Premarket

  • Shell finished Monday’s session in London with shares rising 0.8%.
  • Another round of share buybacks for cancellation was disclosed by the company.
  • Oil pushed closer to levels last seen seven months ago, with prices buoyed ahead of Thursday’s scheduled U.S.-Iran talks.

Shell shares are drawing attention before London’s open this Tuesday, as oil prices edge up near seven-month highs amid fresh U.S.-Iran strains—conditions that tend to move major energy names. “At this stage, geopolitics is clearly doing most of the heavy lifting for oil prices,” said Priyanka Sachdeva, senior market analyst at Phillip Nova. OANDA’s Kelvin Wong echoed that view, calling geopolitical risks the key short-term catalyst for crude. Reuters

Shell shares trading in London (SHEL) added 24.5 pence, up 0.83%, wrapping up the session at 2,965 pence.

Shell disclosed it repurchased 1,119,338 shares for cancellation on Feb. 23, snapping up stock across multiple European venues such as the London Stock Exchange and Euronext Amsterdam. The company cited a volume-weighted average price of roughly 29.54 pounds in London, with Amsterdam trades averaging 33.85 euros. That VWAP figure reflects the average price paid through the session, weighted by the size of each deal.

Shell’s U.S. shares (SHEL) wrapped up Monday’s session in New York at $79.97, then edged up to $80.43 after hours, MarketWatch data show.

Why it matters now: Shell ranks among Europe’s giants, and its stock tends to swing harder than most when crude shifts. Geopolitical news can jolt oil, and when that happens, broad flows hit the indexes, dragging majors like Shell along.

The buyback’s another factor here. Routine repurchases help take some shares out of circulation, supporting per-share stats—though, in reality, they seldom outweigh what the market thinks about crude prices, refining spreads, or gas trading.

Oil traders kept an eye out for hints that tensions could hit supply, but also for signs of a sudden cooling that might erase the risk premium just as quickly. The very headlines that send crude higher can turn on a dime.

Demand is another piece of the puzzle behind the geopolitics. Higher tariffs and softer growth outlooks tend to sap fuel consumption, which can limit gains for integrated producers—even if crude prices hold up.

Shell bulls have something to watch for—a quieter Middle East and weaker crude prices could drag the stock closer to the rest of the market, making buybacks less effective at the edges. A sudden shift in refining margins might also undercut the oil-driven gains.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Figma (FIG) drops 49% this year as DCF flags overvaluation
    June 30, 2026, 1:48 PM EDT. Figma (FIG) shares are down 49.3% year-to-date and off 25.2% in the last month, bringing fresh questions about whether the stock price matches the business. A Discounted Cash Flow (DCF) model just put Figma's fair value at $15.48, which means the stock looks 23.3% overvalued right now. The DCF projects free cash flow could reach $472.6 million by 2030, but it also suggests the market is either seeing extra risk or not buying growth estimates. Simply Wall St gave Figma a 2 out of 6 on valuation. The selloff tracks with a wider reset in software growth names, and investors are split on whether this move is about cooling expectations or the company's outlook getting tougher.
Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod
Previous Story

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod

Apple stock price climbs as Houston Mac mini shift and China vote put tariffs in focus
Next Story

Apple stock price climbs as Houston Mac mini shift and China vote put tariffs in focus

Go toTop